Figure 2From: Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial Accrual at the date of 15 May 2014 (blue lines: current accrual/ red lines: theorical accrual). Back to article page